XML 15 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Income and Comprehensive Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]        
Net revenue $ 500,577 $ 486,033 $ 991,585 $ 968,262
Operating expenses:        
Practice salaries and benefits 354,032 330,757 716,267 673,912
Practice supplies and other operating expenses 31,089 29,843 61,809 58,332
General and administrative expenses 58,013 61,165 117,072 122,452
Depreciation and amortization 8,945 8,775 17,898 17,544
Transformational and restructuring related expenses 0 5,338 0 6,759
Total operating expenses 452,079 435,878 913,046 878,999
Income from operations 48,498 50,155 78,539 89,263
Investment and other income 1,189 844 1,823 1,719
Interest expense (11,230) (8,409) (21,620) (20,227)
Loss on early extinguishment of debt 0 0 0 (57,016)
Equity in earnings of unconsolidated affiliate 490 443 917 948
Total non-operating expenses (9,551) (7,122) (18,880) (74,576)
Income from continuing operations before income taxes 38,947 43,033 59,659 14,687
Income tax provision (10,665) (12,332) (17,171) (4,931)
Income from continuing operations 28,282 30,701 42,488 9,756
Loss from discontinued operations, net of tax 0 (3,565) 0 (3,812)
Net income 28,282 27,136 42,488 5,944
Net loss attributable to noncontrolling interest 0 0 0 4
Net income attributable to Pediatrix Medical Group, Inc. 28,282 27,136 42,488 5,948
Other comprehensive (loss) income, net of tax (387) (1,234) 217 (3,902)
Total comprehensive income attributable to Pediatrix Medical Group, Inc. $ 27,895 $ 25,902 $ 42,705 $ 2,046
Net income attributable to Pediatrix Medical Group, Inc.:        
Basic $ 0.34 $ 0.32 $ 0.52 $ 0.07
Diluted $ 0.34 $ 0.32 $ 0.52 $ 0.07
Weighted average common shares:        
Basic 82,399 85,078 82,033 85,190
Diluted 82,664 85,619 82,377 85,914